Category: Ophthalmology and OMPs
![](https://primaryhealthnet.co.uk/wp-content/uploads/2024/07/Adam-Cockley_headshot_Optegra-268sq.jpg)
OPTEGRA appoints new commercial Director
Optegra are pleased to welcome Adam to the team as we continue to grow and reach out to more and more NHS patients.
Read More..![](https://primaryhealthnet.co.uk/wp-content/uploads/2021/12/Hospitalsign200sq.png)
Optegra eyes up new approach with launch of Cataract Diagnostic Clinics
Optegra Diagnostic Clinics will launch in July near Optegra Hospitals in Manchester & Hampshire
Read More..![](https://primaryhealthnet.co.uk/wp-content/uploads/2021/01/educationgen300.jpg)
Moorfields Education International Uveitis Symposium
Clinical practice, investigations, and therapeutic management of patients with ocular inflammatory diseases and complex uveitic conditions
Read More..![](https://primaryhealthnet.co.uk/wp-content/uploads/2021/12/Hospitalsign200sq.png)
‘At risk’ corneas are more easily identified with score
Screening of Corneal Objective Risk of Ectasia
Read More..![](https://primaryhealthnet.co.uk/wp-content/uploads/2021/12/Hospitalsign200sq.png)
Moorfields Eye Hospital granted royal patronage by King Charles
Moorfields Eye Hospital, is the oldest eye hospital in the world
Read More..![](https://primaryhealthnet.co.uk/wp-content/uploads/2021/12/Hospitalsign200sq.png)
RCOph Sets out Position on AI
AI in ophthalmology has the potential for strengthening patient care, and much more
Read More..![](https://primaryhealthnet.co.uk/wp-content/uploads/2021/12/Hospitalsign200sq.png)
The Office for Health Improvement & Disparities publishes Vision Profile
The Office for Health Improvement & Disparities publishes Vision Profile
Read More..![](https://primaryhealthnet.co.uk/wp-content/uploads/2021/12/Hospitalsign200sq.png)
RNIB Vacancy for Clinical Lead
The Clinical Lead will work alongside the Strategic Engagement Team NHS
Read More..![](https://primaryhealthnet.co.uk/wp-content/uploads/2021/12/Hospitalsign200sq.png)
Developing new therapeutic approach for geographic atrophy
SeaBeLife, a biotechnology company developing drug candidates intended to block cellular necrosis
Read More..![](https://primaryhealthnet.co.uk/wp-content/uploads/2024/04/Chris-Chisholm_Optegra_Portrait-314sq.jpg)
OPTEGRA appoints new Clinical Service Director
Optegra brings together leading-edge research, medical expertise and state-of-the-art surgical equipment
Read More..